Can Mounjaro Help Teenagers Lose Weight? Major Study Finds 18.5% Drop In BMI

Mounjaro for teenagers with obesity (Credits: iStock)

\n\n

Weight-loss injections have become a major talking point in obesity treatment, but could they also help teenagers struggling with excess weight? A new clinical trial published in JAMA has found that tirzepatide, the drug sold under brand names such as Mounjaro, significantly reduced body mass index (BMI) in adolescents living with obesity.

\n\n

The Phase 3 SURMOUNT-ADOLESCENTS trial, published online on November 15, 2026, investigated the effects of once-weekly tirzepatide in 160 adolescents aged 12 to under 18 years. The findings showed that participants receiving the medication experienced an average 18.5% reduction in BMI over 72 weeks, compared with a 0.5% increase among those given a placebo.

\n\n

The study involved adolescents with obesity or those who were overweight and had at least one obesity-related health complication. Participants were divided into two groups, with 109 receiving tirzepatide and 51 receiving a placebo. Both groups also received lifestyle support, including guidance on healthy eating and increased physical activity.

\n\n

The results were particularly significant when researchers examined how many participants achieved different levels of BMI reduction. Around 79.6% of adolescents receiving tirzepatide recorded at least a 5% reduction in BMI. Meanwhile, 71.4% achieved a reduction of at…

Original source: https://www.timesnownews.com/lifestyle

Leave a Reply

Your email address will not be published. Required fields are marked *